PROCEPT BioRobotics Corporation Cash and Restricted Cash
PROCEPT BioRobotics Corporation (PRCT) had Cash and Restricted Cash of $230.95 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-05
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $230.95M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $248.68M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $289.54M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $297.32M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $230.95M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $248.68M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $289.54M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $297.32M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $305.75M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $319.25M 10-Q · filed 2026-04-30 |
| 2024-12-31 | $336.76M 10-Q · filed 2026-08-05 |
| 2024-09-30 | $199.80M 10-Q · filed 2025-11-05 |
| 2024-06-30 | $217.13M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $228.61M 10-Q · filed 2025-05-02 |
| 2023-12-31 | $260.26M 10-K · filed 2026-02-26 |
| 2023-09-30 | $290.90M 10-Q · filed 2024-10-28 |
| 2023-06-30 | $153.51M 10-Q · filed 2024-08-02 |
| 2023-03-31 | $184.79M 10-Q · filed 2024-05-02 |
| 2022-12-31 | $225.67M 10-K · filed 2026-02-26 |
| 2022-09-30 | $253.03M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $273.62M 10-Q · filed 2023-07-28 |
| 2022-03-31 | $288.10M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $305.10M 10-K · filed 2025-02-27 |
| 2021-09-30 | $321.26M 10-Q · filed 2022-11-04 |
| 2021-06-30 | $160.00M 10-Q · filed 2022-08-05 |
| 2021-03-31 | $86.89M 10-Q · filed 2022-05-06 |
| 2020-12-31 | $100.91M 10-K · filed 2024-02-28 |
| 2020-09-30 | $114.12M 10-Q · filed 2021-11-05 |
| 2019-12-31 | $42.71M 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |